Equasens

EQS

FR0012882389

IT Services & Consulting

Market Closed - Euronext Paris Other stock markets 11:35:17 2024-04-26 am EDT			5-day change	1st Jan Change
58 ^EUR	-2.52%		-0.17%	-5.07%

Apr. 02	Equasens : RNPG virtually stable in 2023	CF
Mar. 29	Equasens Société Anonyme Provides Revenue Guidance for the 2025	CI

Equasens Société anonyme acquired Atoopharm.

April 11, 2023

Equasens Société anonyme (ENXTPA:EQS) acquired Atoopharm on April 12, 2023.

Equasens Société anonyme (ENXTPA:EQS) completed the acquisition of Atoopharm on April 12, 2023.

Latest news about Equasens

Equasens : RNPG virtually stable in 2023	Apr. 02	CF
Equasens Société Anonyme Provides Revenue Guidance for the 2025	Mar. 29	CI
Equasens Société anonyme Proposes Gross Dividend	Mar. 29	CI
Equasens: annual sales growth of almost 3%	Feb. 07	CF
Equasens Société Anonyme Reports Consolidated Revenue Results for the Fourth Quarter and Full Year of 2023	Feb. 06	CI
Global markets live: Airbus, Tesla, HSBC, KKR, Pfizer...	Jan. 03
Equasens to Acquire 70% Stake in Digipharmacie	Jan. 02	MT
Equasens: acquires 70% stake in Digipharmacie	Jan. 02	CF
Equasens Société anonyme acquired 70% stake in Digipharmacie.	Jan. 01	CI
Equasens: changes to the management committee	Dec. 27	CF
Equasens Group Announces Management Appointments, Effective 1 January 2024	Dec. 27	CI
CAC40: up slightly, stalls at the 7300 pts mark	Nov. 24	CF
Equasens: share price up, broker confirms its recommendation	Nov. 24	CF
EQUASENS : Stifel maintains its recommendation on the share	Nov. 24	CF
Equasens: acquisition of German company ADV	Nov. 24	CF
Equasens, Arz Haan Buy German Pharmacy Software Group Apotheken Datenverarbeitung	Nov. 24	MT
Equasens Société anonyme and ARZ Haan AG acquired Ad Apotheken Datenverarbeitung Gmbh & Co. Kg.	Nov. 22	CI
EQUASENS : Stifel lowers its target price	Nov. 15	CF
Stifel Cuts Equasens PT, Affirms Hold Rating	Nov. 10	MT
EQUASENS : Stifel lowers its target price	Nov. 10	CF
Equasens: sales stable in Q3	Nov. 10	CF
Equasens Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023	23-10-04	CI
Equasens: 11% increase in half-year net income	23-10-02	CF
Equasens: 9% growth in half-year sales	23-08-04	CF
Equasens Société anonyme Reports Consolidated Sales Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-03	CI

Equasens is No. 1 in France for publishing and integrating software programs for pharmacies, hospitals, healthcare facilities, laboratories, retirement homes and healthcare professionals. Net sales break down by activity as follows: - pharmacy software publishing and integration (73%): software programs for managing data bases, information, inventories, orders, electronic care records, etc.; - publishing of IT solutions for health and medical/social establishments (15.2%): publishing and integration of software packages for retirement homes, hospitals and care homes (software for managing admissions, billing, receipt and accounting management, care management, supply management, etc.); - development of solutions and infrastructures for e-Health (11.8%): digital communication, telemedicine and telehealth solutions. The group also offers financing solutions for leased goods (Nanceo). Net sales are distributed geographically as follows: France (90.9%), Italy (4.9%), Belgium and Luxembourg (2.7%), Ireland and the United Kingdom (0.8%) and Germany (0.7%).

Sector

IT Services & Consulting

Calendar

2024-05-06 - Q1 2024 Sales and Revenue Release

More about the company

Income Statement Evolution

More financial data

Ratings for Equasens

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

58 EUR

Average target price

71.25 EUR

Spread / Average Target

+22.84%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other IT Services & Consulting

	1st Jan change	Capi.
EQUASENS	-5.07%	931M
ACCENTURE PLC	-12.23%	194B
TATA CONSULTANCY SERVICES LTD.	+0.74%	166B
IBM	+2.19%	153B
AUTOMATIC DATA PROCESSING, INC.	+4.34%	99.85B
RELX PLC	+7.04%	77.56B
CROWDSTRIKE HOLDINGS, INC.	+19.09%	73.55B
INFOSYS LIMITED	-7.30%	71B
SNOWFLAKE INC.	-20.54%	52.81B
HCL TECHNOLOGIES LIMITED	+0.53%	47.86B

Other IT Services & Consulting

Equasens

Equities

EQS

FR0012882389

IT Services & Consulting

Equasens Société anonyme acquired Atoopharm.

Latest news about Equasens

Chart Equasens

Company Profile

Income Statement Evolution

Ratings for Equasens

Analysts' Consensus

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Other IT Services & Consulting